share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  2024/10/03 04:36

Moomoo AI 已提取核心訊息

Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
Arcutis Biotherapeutics, Inc. officer Larry Todd Edwards is set to sell 3,725 shares of common stock on October 2, 2024. The shares, valued at an aggregate market value of $37,295, were acquired through a restricted stock vest on October 1, 2024, directly from Arcutis Biotherapeutics. This transaction follows a period where no securities were sold by Edwards in the past three months, as per the provided transaction history.
arctuis biotherapeutics公司官員拉里·託德·愛德華茲計劃於2024年10月2日賣出3725股普通股。這些股票的總市值爲37295美元,是通過2024年10月1日直接從arctuis biotherapeutics獲得的限制性股票歸屬而來。此次交易是在過去三個月中愛德華茲未賣出任何證券的情況下進行的,根據提供的交易歷史記錄。
arctuis biotherapeutics公司官員拉里·託德·愛德華茲計劃於2024年10月2日賣出3725股普通股。這些股票的總市值爲37295美元,是通過2024年10月1日直接從arctuis biotherapeutics獲得的限制性股票歸屬而來。此次交易是在過去三個月中愛德華茲未賣出任何證券的情況下進行的,根據提供的交易歷史記錄。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息